Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, is proud to announce the FDA clearance of its latest product,...
Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling...
Exo®, a medical imaging software and devices company, announced its FDA-cleared cardiac and lungartificial intelligence (AI) applications are now available on Exo Iris™, Exo’s...
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of time
Epitel, a leader in AI...
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant...
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is...
Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, announced that the U.S. Patent and Trademark Office (USPTO) issued...